Ymmunobio

  • Biotech or pharma, therapeutic R&D

Ymmunobio is a pre-clinical stage Biotech company focusing on first in class solid tumor treatments. Their novel target has superior properties (highest prevalence, large presence and not expressed in normal tissue).

Address

Basel
Switzerland

Website

https://www.ymmuno.bio

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS